King's College London

The study specifically analysed “gene expression”, the process by which the instructions that are held in our genes are expressed, influencing bodily functions.

Approximately one in three people with depression have high levels of inflammation, an activation of the immune system, our body’s defence against potentially harmful stimuli, such as infections. During stress, inflammation is activated to effectively fight threats, and it is likely the reason that the immune system is activated in depression, which is a condition of chronic stress.

Individuals with depression and inflammation present a greater risk of not responding to standard antidepressants, and they might benefit from additional treatments targeting the immune system, such as anti-inflammatories. Thus, understanding the biological mechanisms underpinning this increased inflammation could also shed light on ways to help people with depression, especially those who do not respond to standard antidepressants.

Researchers used a technology called “mRNA sequencing” to measure the activity of all the genes expressed in the blood. The study found that individuals with depression who had increased levels of inflammation showed increased activity of genes linked with the immune system and with the metabolic activity.

The study found that that even with moderately increased inflammation, there is a significant activation of immune-related genes, while people with depression and very high levels of increased inflammation there is additional activation of genes involved in metabolic processes, that is, related to how we produce, consume and store energy, relevant, for example, to fat and sugar functions in the body.

In the study, the researchers also identified a specific gene expression profile in individuals who had effectively responded to an antidepressant, with changes in biological mechanisms relevant not only to inhibition of the immune function but also to the protection of the brain, suggesting that these biological processes may play a role in these people’s recovery from depression and in the way antidepressants work.

Overall, the present study demonstrates the importance of gene expression in understanding the biology of depression and of antidepressant actions. Our genes and their associated biological patterns might explain the differences between different types of depression, such as those who do or do not respond to standard antidepressants, or those who do or do not develop medical comorbidities like diabetes and cardiovascular problems.

Transcriptomic profiles in major depressive disorder: the role of immunometabolic and cell-cycle-related pathways in depression with different levels of inflammation. (Sforzini, L. et al) was published in Molecular psychiatry, 10.1038/s41380-024-02736-w.  https://doi.org/10.1038/s41380-024-02736-w